Evidence map›Paper›PMID 34740011›Full record

ArticleJournal of the mechanical behavior of biomedical materials2022

Fluorapatite and fluorohydroxyapatite apatite surfaces drive adipose-derived stem cells to an osteogenic lineage.

Sujee Jeyapalina, Elaine Hillas, James Peter Beck, Jayant Agarwal, Jill Shea

Open access · greenAbstract read
In one paragraph

Article in Journal of the mechanical behavior of biomedical materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Low Percent Copper Doping Limits Bacterial Adhesion on Fluorapatite-Based Bone Scaffolds.Journal of biomedical materials research. Part B, Applied biomaterials · 2026
    Article
  2. Article
  3. Sintered fluorapatite scaffolds as an autograft-like engineered bone graft.Journal of biomedical materials research. Part B, Applied biomaterials · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sujee JeyapalinaDivision of Plastic Surgery, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA; Orthopaedic and Plastic Surgery Research Laboratory, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, 84148, USA; Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
Elaine HillasDepartment of Surgery, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
James Peter BeckOrthopaedic and Plastic Surgery Research Laboratory, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, 84148, USA; Department of Orthopaedics, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
Jayant AgarwalDivision of Plastic Surgery, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA; Orthopaedic and Plastic Surgery Research Laboratory, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, 84148, USA; Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
Jill SheaOrthopaedic and Plastic Surgery Research Laboratory, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, 84148, USA; Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA. Electronic address: jill.shea@hsc.utah.edu.
University of Utah · US

Funding

Heat-Treated Porous Fluorapatite Scaffolds with Adipose Derived Stem Cells for Bone RegenerationI21RX003328 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI AGARWAL, JAYANT PRASAD · 2020 to 2022
–
RRD VA I01 RX003911RRD VA I21 RX003328
6 · The paper itself

Abstract

purposeHydroxyapatite (HA) scaffolds are common replacement materials used in the clinical management of critical-sized bone defects. This study was undertaken to examine the potential benefits of fluoridated derivatives of hydroxyapatite, fluorapatite (FA), and fluorohydroxyapatite (FHA) as bone scaffolds in conjunction with adipose-derived stem cells (ADSCs). If FHA and FA surfaces could drive the differentiation of stem cells to an osteogenic phenotype, the combination of these ceramic scaffolds with ADSCs could produce materials with mechanical strength and remodeling potential comparable to autologous bone. This study was designed to investigate the ability of the apatite surfaces HA, FA, and FHA produced at different sintering temperatures to drive ADSCs toward osteogenic lineages.

methodsHA, FHA, and FA surfaces sintered at 1150 °C and 1250 °C were seeded with ADSCs and evaluated for cell growth and gene and protein expression of osteogenic markers at 2 and 10 days post-seeding.

resultsIn vitro, ADSC cells were viable on all surfaces; however, differentiation of these cells into osteoblastic lineage only observed in apatite surfaces. ADSCs seeded on FA and FHA expressed genes and proteins related to osteogenic differentiation markers to a greater extent by Day 2 when compared to HA and cell culture controls. By day 10, HA, FA, and FHA all expressed more bone differentiation markers compared to cell culture controls.

conclusionFA and FHA apatite scaffolds may promote the differentiation of ADSCs at an earlier time point than HA surfaces. Combining apatite scaffolds with ADSCs has the potential to improve bone regeneration following bone injury.

Indexed as

ApatitesOsteogenesisHydroxyapatitesStem CellsApatitesfluorapatitefluorohydroxyapatiteHydroxyapatitesAdipose derived stem cellsBone scaffoldDifferentiationFluoridated hydroxyapatiteHydroxyapatite

Identifiers

PMID34740011
PMCPMC11822887
OpenAlexW3208706183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.